Chordate Medical Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was SEK 1.1 million compared to SEK 0.08817 million a year ago. Revenue was SEK 1.25 million compared to SEK 0.123296 million a year ago. Net loss was SEK 19.34 million compared to SEK 19.48 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.12 a year ago.